Application 008693
- Type
- NDA
- Sponsor
- PROCTER AND GAMBLE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FURADANTIN | NITROFURANTOIN | TABLET;ORAL | 50MG | No | No |
| 002 | FURADANTIN | NITROFURANTOIN | TABLET;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N008693-001 | FURADANTIN | NITROFURANTOIN | 50MG | TABLET / ORAL | Approved before 1982 | ||
| N008693-002 | FURADANTIN | NITROFURANTOIN | 100MG | TABLET / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N008693-001 | FURADANTIN | 50MG | TABLET / ORAL | Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N008693-002 | FURADANTIN | 100MG | TABLET / ORAL | Approved before 1982 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nitrofurantoin | NITROFURANTOIN | Aurobindo Pharma Limited | e9d10eaa-cf9c-469e-82ef-5af7285f2c86 | 2024-03-15 | Warnings, Adverse reactions | NITROFURANTOIN |
| Nitrofurantoin | NITROFURANTOIN | Bryant Ranch Prepack | bebbe5d6-f6ec-4191-bad3-b6e933da0688 | 2024-03-15 | Warnings, Adverse reactions | NITROFURANTOIN |
| Nitrofurantoin | NITROFURANTOIN | Amneal Pharmaceuticals NY LLC | 80129dba-5939-4292-bfd0-8d53ba165941 | 2024-02-26 | Warnings, Adverse reactions | NITROFURANTOIN |
| Nitrofurantoin | NITROFURANTOIN | Bryant Ranch Prepack | 75dab97e-59b4-447c-a8c9-b4d5a970098f | 2024-01-04 | Warnings, Adverse reactions | NITROFURANTOIN |
| Nitrofurantoin | NITROFURANTOIN | Bryant Ranch Prepack | b807bd48-71ab-4578-b1d7-4d3260bf6c75 | 2023-10-02 | Warnings, Adverse reactions | NITROFURANTOIN |
| Nitrofurantoin | NITROFURANTOIN | Trigen Laboratories, LLC | 39ffb8c6-4dd8-4436-b857-7306c15f662a | 2023-05-11 | Warnings, Adverse reactions | NITROFURANTOIN |
| NITROFURANTOIN | NITROFURANTOIN | Alembic Pharmaceuticals Inc. | a8a0d7d7-1e18-46a7-a1f8-e97499820035 | 2023-05-05 | Warnings, Adverse reactions | NITROFURANTOIN |
| NITROFURANTOIN | NITROFURANTOIN | Alembic Pharmaceuticals Limited | 152e4fe2-7665-4725-af76-b241bd816937 | 2023-01-30 | Warnings, Adverse reactions | NITROFURANTOIN |
| Nitrofurantoin | NITROFURANTOIN | Proficient Rx LP | 34d3c103-27b8-454b-9f38-c33157c3b6fc | 2022-11-01 | Warnings, Adverse reactions | NITROFURANTOIN |
| Nitrofurantoin | NITROFURANTOIN | Lupin Pharmaceuticals,Inc. | 93c37857-38f1-4e2e-acb8-4846840e3e85 | 2022-06-02 | Warnings, Adverse reactions | NITROFURANTOIN |
| Nitrofurantoin | NITROFURANTOIN | Novel Laboratories, Inc. | 499f9dfd-b533-4021-a3ed-308f0f956c79 | 2016-11-14 | Warnings, Adverse reactions | NITROFURANTOIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 20014 | SUPPL | 2006-05-10 |